AMC Entertainment Holdings, Inc. and Cinemark Holdings, Inc. stand as the two largest publicly traded movie theater operators in the United States, which makes them a natural comparison for anyone following the post-pandemic recovery in theatrical exhibition. Both companies are benefiting from renewed moviegoing and a stronger lineup of releases, yet they sit in quite different places when it comes to financial strength, profitability, and how the market views them. This kind of side-by-side look matters most to traders and investors deciding how much exposure they want to the exhibition sector—whether they lean toward the higher-beta, turnaround profile of AMC or the steadier, cash-generating approach of CNK. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.
AMC is the largest theater chain in the U.S., with a sizable international presence that operates mainly under the Odeon brand in Europe. The stock has posted strong gains this year, ranking among the bigger movers in the exhibition group. Much of that lift has come from balance-sheet developments rather than headline profits: the company wrapped up a large-scale refinancing that pushed most debt maturities out into the next decade and eased near-term solvency concerns.
On the operations side, AMC has posted record quarterly revenue and a notable rise in adjusted EBITDA, helped by higher attendance, premium large-format screens such as IMAX and Dolby, and increased food-and-beverage spending per guest. Its A-List subscription and AMC Stubs loyalty programs help drive repeat visits. Even with those positives, the company still holds billions in debt and negative stockholders’ equity, and share issuance has diluted existing owners—elements that keep both sentiment and volatility elevated. From what I see, these factors continue to shape how the market prices the name.
CNK (Cinemark) runs a smaller, less leveraged circuit across the U.S. and Latin America, featuring premium formats that include Cinemark XD, IMAX, ScreenX, and D-BOX. The same box-office momentum has translated into record results here as well: worldwide revenue topped $1 billion in a single quarter for the first time, and adjusted EBITDA hit an all-time high with margins near historical peaks.
Unlike AMC, CNK is profitable on a trailing basis, produces positive free cash flow, and pays a modest quarterly dividend. Growth is being supported by premium-format expansion, solid Latin American results, rising attendance among younger viewers, and a growing merchandise business. The stock has delivered a solid year-to-date gain, though its valuation tends to track more closely with film-release timing and operating costs such as electricity rather than refinancing news.
The clearest difference lies in financial health. AMC combines the industry’s largest footprint with its heaviest debt load and negative equity, so its shares can act partly like a leveraged bet on sustained box-office recovery and lower interest costs. CNK, by contrast, offers profitability, cash flow, and a dividend, but with less upside leverage and lower share-price volatility.
The two also diverge on geography and growth drivers. AMC relies on its U.S. scale, premium screens, loyalty base, and newer live-event initiatives. CNK focuses on disciplined capital allocation, premium-format growth, Latin American market-share gains, and merchandise. On the risk side, AMC faces refinancing and dilution concerns, while CNK is more exposed to release-slate timing and cost inflation. One thing that stands out is how these differences show up in day-to-day price behavior.
Based on observable factors, Tickeron’s AI would likely favor CNK on stability and trend consistency, given its profitability, positive cash flow, lower leverage, and dividend. AMC may show stronger short-term momentum and higher beta-driven upside, but its negative equity and balance-sheet sensitivity bring greater uncertainty. A probabilistic framework would therefore tend to assign higher relative positioning to CNK for consistency, while treating AMC as a higher-risk, catalyst-dependent alternative. I’m watching this closely as the box-office recovery plays out.
In my own research process I often turn to Tickeron’s AI Trading Bots to test how different automated strategies are positioned in names like these. The platform offers a wide range of bots with varying styles, timeframes, and performance histories, which helps me filter for approaches that align with my risk tolerance. It is a practical way to add another layer of data when comparing stocks in a sector like exhibition.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for CNK crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on CNK as a result. In 56 of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for CNK just turned positive on October 13, 2026. Looking at past instances where CNK's MACD turned positive, the stock continued to rise in 30 of 36 cases over the following month. The odds of a continued upward trend are 83%.
CNK moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNK advanced for three days, in 236 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 217 of 291 cases where CNK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The 10-day RSI Indicator for CNK moved out of overbought territory on October 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 51 similar instances where the indicator moved out of overbought territory. In 33 of the 51 cases, the stock moved lower in the following days. This puts the odds of a move lower at 65%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 54 cases where CNK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
CNK broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 29 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. CNK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.243) is normal, around the industry mean (12.531). P/E Ratio (21.253) is within average values for comparable stocks, (38.781). Projected Growth (PEG Ratio) (1.860) is also within normal values, averaging (2.376). Dividend Yield (0.009) settles around the average of (0.046) among similar stocks. P/S Ratio (1.165) is also within normal values, averaging (2.932).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of movie theaters
Industry MoviesEntertainment